Analytical Research

Contextualizing Research Processes

Private Sector Engagement

Private Section Engagement on RUTFs at the Presidential Villa

Robust Engagement

Dr Obi Adigwe, DG NIPRD presenting ASICC-19 documents to Vice President, Prof. Yemi Osinbajo

Partnership Development

Dr Adigwe presenting a Business Feasibility Plan on CPP to the Kaduna State Government

NIPRD Laboratory Complex

Head office of the National Institute for Pharmaceutical Research and Development

ASICC-19

Prof Yemi Osinbajo with Dr. John Alfa and Dr. Obi Adigwe shortly after declaring the All-stakeholders'Int'l Conference on COVID-19 (ASICC-19) open

International Collaboration

Chief Diana Chen, Chair CABC Collaborative Visit to DG NIPRD

Welcome message from the Director-General / CEO

The National Institute for Pharmaceutical Research and Development (NIPRD) is a Federal Government Parastatal under the Federal Ministry of Health. The Agency was established by Government Order No. 33 Vol. 74 of 11th June 1987 Part B under the Science and Technology Act Cap 276. It became functional in the year 1989. In 2001 following a Federal Executive Council decision, NIPRD was moved to the Federal Ministry of Health (FMOH), with a huge investment in scientific equipment and human resources.

NIPRD is the only one of its kind in the Region, and is statutorily charged with the responsibility for research and development of drugs, vaccines, phytomedicines, commodities, and diagnostics aimed at improving sustainable access to safe, affordable and high-quality healthcare. Read more…

"NIPRD is taking the lead, especially with innovative concepts like the CPP project"

"NIPRD intervention leverages the systems approach to ensure that while its projects improve access to health, it also makes significant impact on relevant socioeconomic variables"

"At no time in our Nation’s history is NIPRD relevant more than now when President Muhammadu Buhari is determined to implement Universal Health Coverage for our people."

The conceptualization of NIPRD HEEAD is a direct response to the gap in the Health Sector. This approach ensures a robust and comprehensive engagement with seminal and topical issues, in a manner that is contextual enough to expeditiously impact on our people’s health.

. Dr Obi Adigwe, DG NIPRD . Tweet

Get our COVID-19 Advisory

NSP-II and M&E Plan (2021 - 2025)

Follow NIPRD on Twitter

My Tweets

Recent Blogs

International Conference on Health Access and Socio-Economic Development Beyond COVID-19 (ASICC-19)

July 23, 2021 No Comments

ASICC-19 Opening Presidential Statement Opening – 18th October, 2021 Nigeria Has What It Takes To Become A Leader In Healthcare, Says Osinbajo Know more… Nigeria,

Webinar Conference (Series 3.0) on “Improving Access to COVID-19 Vaccines and other Interventions: Intellectual Property, Patent Waivers and other Critical Factors” PRESS RELEASES

June 24, 2021 No Comments

Express Day Nigeria can lead vaccines production in Africa- NIPRD DG Independent Nigeria Can Lead Vaccines Production In Africa – NIPRD DG Vanguard With right

Community Engagement with the Jiwa Chiefdom

March 12, 2021 No Comments

Dr. Obi Adigwe, Director General, NIPRD with HRH the Emir of Jiwa Chiefdom, Dr. Alh. Musa Idrisu Charting path for continued mutual coexistence Dr. Obi

Ministerial Health Sector Media Engagement

December 10, 2020 No Comments

Ministerial Health Sector Media Engagement National Institute for Pharmaceutical Research and Development (NIPRD) had a robust engagement and made its presence known by showcasing some